Ampio Pharmaceuticals (AMPE) Stock Statistics & Valuation Metrics

Ampio Pharmaceuticals has a market cap or net worth of $207.88K. The enterprise value is -$3.61M.

Ampio Pharmaceuticals has 1,135,358 shares outstanding. The number of shares has decreased by -2.65% in one year.

Ampio Pharmaceuticals’s return on equity (ROE) is -2.57 and return on invested capital (ROIC) is -252.47%.

The current PE Ratio of Ampio Pharmaceuticals is ―. Ampio Pharmaceuticals’s PEG ratio is 0.04.

In the last 12 months, Ampio Pharmaceuticals had revenue of 0.00 and earned -8.63M in profits. Earnings per share was -10.67.

In the last 12 months, operating cash flow was -8.56M and capital expenditures 0.00, giving a free cash flow of -8.56M billion.

Ampio Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Ampio Pharmaceuticals upcoming earnings date is May 9, 2024, TBA (Confirmed).

Ampio Pharmaceuticals as a current ratio of 2.41, with Debt / Equity ratio of 8.15%

In the past 12 months, Ampio Pharmaceuticals has paid 0.00 in taxes.

Ampio Pharmaceuticals EV to EBITDA ratio is 0.26, with an EV/FCF ratio of 0.25.

Ampio Pharmaceuticals has $4.09M in cash and marketable securities with $274.00K in debt, giving a net cash position of $3.81M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Ampio Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―